Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 0.94 | 1.12 | 1.22 | 2.06 |
| Operating Revenue | - | 0.94 | 1.12 | 1.22 | 2.06 |
| Cost Of Revenue | - | - | 0 | 4.53 | 18.83 |
| Gross Profit | - | - | 1.12 | -3.31 | -16.77 |
| Operating Expense | - | 25.61 | 24.80 | 72.48 | 101.37 |
| Research And Development | - | 15.44 | 4 | 11.32 | 25.02 |
| Selling General And Administration | - | 10.17 | 20.79 | 61.16 | 76.34 |
| Total Expenses | - | 25.61 | 24.80 | 77.01 | 120.20 |
| Operating Income | - | -24.67 | -23.68 | -75.79 | -118.14 |
| Total Operating Income As Reported | - | -24.67 | -23.68 | -75.79 | -464.70 |
| EBITDA | - | -31.90 | -29.75 | -91.82 | -456.65 |
| Normalized EBITDA | - | -24.87 | -23.54 | -92.86 | -92.13 |
| EBIT | - | -31.90 | -29.76 | -97.42 | -479.16 |
| Interest Expense | - | 0.89 | 1.22 | 2.43 | 9.68 |
| Net Interest Income | - | -0.89 | -1.22 | -2.43 | -9.68 |
| Other Non Operating Income Expenses | - | -0.14 | 0.77 | -22.66 | 16.10 |
| Other Income Expense | - | -7.23 | -6.08 | -21.64 | -361.01 |
| Interest Expense Non Operating | - | 0.89 | 1.22 | 2.43 | 9.68 |
| Net Non Operating Interest Income Expense | - | -0.89 | -1.22 | -2.43 | -9.68 |
| Pretax Income | - | -32.78 | -30.98 | -99.86 | -488.83 |
| Tax Provision | - | 0 | 0 | -3.28 | -13.48 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 0 | 0 | 0.03 | -10.05 |
| Net Income Continuous Operations | - | -32.78 | -30.98 | -96.57 | -475.35 |
| Net Income From Continuing And Discontinued Operation | - | -32.76 | -30.84 | -76.47 | -293.32 |
| Net Income From Continuing Operation Net Minority Interest | - | -32.76 | -30.84 | -76.47 | -293.32 |
| Net Income | - | -32.76 | -30.84 | -76.47 | -293.32 |
| Net Income Common Stockholders | - | -32.76 | -30.84 | -76.47 | -293.32 |
| Net Income Including Noncontrolling Interests | - | -32.78 | -30.98 | -96.57 | -475.35 |
| Normalized Income | - | -25.73 | -24.63 | -77.48 | 61.15 |
| Diluted NI Availto Com Stockholders | - | -32.76 | -30.84 | -76.47 | -293.32 |
| Basic Average Shares | - | 42.70 | 42.70 | 44.60 | 54.42 |
| Diluted Average Shares | - | 42.70 | 42.70 | 44.60 | 54.42 |
| Reconciled Depreciation | - | - | 0.01 | 5.60 | 22.51 |
| Reconciled Cost Of Revenue | - | - | 0 | 4.53 | 18.83 |
| Total Unusual Items | - | -7.02 | -6.22 | 1.04 | -364.52 |
| Total Unusual Items Excluding Goodwill | - | -7.02 | -6.22 | 1.04 | -364.52 |
| Minority Interests | - | 0.03 | 0.14 | 20.10 | 182.03 |
| Special Income Charges | - | - | 0 | -10.04 | -366.16 |
| Other Special Charges | - | - | - | - | 19.60 |
| Write Off | - | - | 0 | 10.04 | 0 |
| Impairment Of Capital Assets | - | - | - | 0 | 346.56 |
| Gain On Sale Of Security | 12.30 | -7.02 | -6.22 | - | 1.64 |
| General And Administrative Expense | - | 9.01 | 17.59 | 54.98 | 66.71 |
| Other Gand A | - | 9.01 | 17.59 | 54.98 | 66.71 |
| Selling And Marketing Expense | - | 1.16 | 3.20 | 6.19 | 9.63 |
| Earnings From Equity Interest | - | -0.06 | -0.63 | -0.01 | -12.59 |
